Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-041)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.
ClinicalTrials.gov Identifier:
NCT00393354
First received: October 26, 2006
Last updated: November 27, 2015
Last verified: November 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2000
  Primary Completion Date: November 2000 (Final data collection date for primary outcome measure)